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Abstract
Pulmonary artery embolism (PE) is a rare and life-threatening complication in the neonate. We
describe two previously stable infants who incurred respiratory failure from PE. The first case is
a late preterm infant with gastroschisis with autopsy confirmation of PE presumably as a result
of a central venous line (CVL) with thromboembolism. The second case is an extreme low birth
weight infant with sudden onset of respiratory failure, abnormal chest x-ray, disseminated
intravascular coagulation (DIC), and echocardiographic confirmation of a thrombus at the
junction of the superior vena cava and right atrium (SVC/RA) at the site of a previous CVL.
This infant was successfully managed with thrombolytic therapy and anticoagulation. We
suggest that PE be considered in an infant with a history of a CVL who presents with otherwise
unexplained respiratory failure.

Introduction
Neonatal thrombosis occurs in 5.1 per 100,000 births [1] and 2.4 per 1000 admissions to the
neonatal intensive care unit.[2] Excluding renal vein thrombosis, 45% of cases are arterial.[2] PE
occurs in 0.86 per 10,000 hospitalized children age one month to 18 years.[3]
This report describes the clinical aspects of two previously stable premature infants with acute
onset of respiratory failure from confirmed or suspected PE. One case has autopsy confirmed
massive PE with a suspected source of a femoral venous line with venous thrombosis, and the
other has presumed PE with echocardiographic evidence of a thrombus located at the junction of
the SVC/RA, the site of a previous CVL.
We present these two cases to add to the body of literature on the clinical presentation of PE in
the neonate and describe the successful medical treatment in one case.
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Case One
A 2070 gram female with gastroschisis and colonic atresia was delivered at our hospital at 34
weeks by dates. After fluid resuscitation, a surgical repair was undertaken. A peripherally
inserted central catheter (PICC) was placed for parenteral alimentation on the first day of life. On
day of life 14 the PICC was replaced with a right femoral venous catheter. On day of life 39 the
infant developed staphylococcus epidermidis sepsis treated with vancomycin through the central
line. Doppler ultrasound of the interior vena cave (IVC), SVC, jugular and subclavian veins
showed no thrombus; however, the IVC and SVC were poorly visualized. On day of life 44 a
left femoral venous catheter was placed. On day of life 45 swelling and bluish discoloration of
the left leg were noted. Superficial veins on the abdominal wall were also more prominent. The
femoral line was functioning well with good blood return. X-rays of the left hip and thigh were
negative for fracture or osteomyelitis. Repeat doppler ultrasound of the iliofemoral veins and
IVC showed no venous thrombus. The edema improved over the next twelve hours. Platelet
counts ranged from 115,000-190,000. On day of life 50 the infant suddenly developed
hypotension, hypoxemia, and bradycardia. The infant failed to respond to resuscitation and was
pronounced dead. At autopsy the contents of the pulmonary artery showed an organized
thrombus (Figure 1) characterized by red cells, layering fibrin, and inflammatory cells.

Figure 1. Cross-section through the pulmonary artery containing an organized, fibrous clot.
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Figure 2. A peripheral lung vessel with an organized thrombus including fibrin and inflammatory cells.

Examination of the lungs revealed multiple microscopic emboli (Figure 2). No thrombophilia
work-up was performed.

Case Two
A 740 gram female was delivered at our hospital at 26 weeks gestation by emergency cesarean
section for abruptio placentae. The infant was initially managed with nasal intermittent positive
pressure ventilation and was weaned to room air on day of life 4. No umbilical line was used. A

5

PICC was placed on the second day of life and was discontinued on day of life 14 when full
enteral feedings were achieved. On day of life 16 the infant developed episodes of apnea and
bradycardia requiring intubation and mechanical ventilation. No blood or milk was noted from
the endotracheal tube. Chest x-ray showed diffuse bilateral pulmonary infiltrates. Because of
worsening hypoxia, inhaled nitric oxide (iNO) was begun. CBC showed a white blood cell count
of 4800 and evidence of DIC (platelet count 25,000, PT and PTT prolonged, D-dimer elevated).
Platelets, fresh frozen plasma, and intravenous immune globulin were given. There was no fall
in hematocrit, an echocardiogram showed a 7x3mm thrombus at the junction of the SVC/RA
(Figure 3) corresponding to the position of the tip of the previous PICC.

Figure 3. Subcostal sagittal view demonstrating a 7 x 4 mm thrombus (Th) at the junction of the superior
vena cava (SVC)-right atrium (RA).
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A PICC was inserted 1 cm proximal to the thrombus and tissue type plasminogen activator (tPA) was administered at 0.2 mg/kg/hour. After 36 hours of t-PA administration, the thrombus
measured 3x2mm. The t-PA was discontinued and low-molecular-weight heparin (LMWH) was
begun at 2mg/kg SQ q12hours and adjusted to achieve target anti-factor Xa levels of 0.5-1.0
units/ml. No excess bleeding was noted except at venipuncture sites and this was controlled with
pressure. Coagulation studies returned to normal. Head ultrasounds showed no intraventricular
bleeding prior to or after t-PA administration. On day of life 25 the thrombus measured 1x1mm
and the chest x-ray was clear of infiltrates. The LMWH was discontinued. All bacterial, fungal
and viral cultures were negative and antibiotics were stopped after 72 hours. The infant was
discharged home on day of life 86 weighing 1800 grams with resolution of the thrombus by
echocardiogram. Laboratory evaluation at 4 months of age for prothrombotic disorders
including Factor V Leiden, protein S, protein C, antithrombin, and prothrombin G20210A were
negative.

Discussion
The frequency of PE in the first 30 days of life is unknown, but likely underestimated because
clinical features are often masked by a primary respiratory illness. In a review of autopsy cases
of PE in childhood, the antemortem diagnosis was considered in only one third of patients.[4]
PE in the neonate can be asymptomatic, mimic congenital heart disease, or present with
respiratory failure, right heart failure, or persistent pulmonary hypertension of the newborn.[5-7]
In addition, PE in children has been reported in association with DIC.[8] We have presented two
cases with divergent histories who both presented with sudden onset of respiratory failure from
confirmed or suspected PE. In Case One, despite clinical symptoms of venous obstruction, the
diagnosis of PE was not considered until autopsy. In Case Two, either pneumonia or pulmonary
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hemorrhage was thought to be the most probable diagnosis until an echocardiogram revealed a
large thrombus at the SVC/RA junction. While the radiographic appearance of PE in the neonate
is unknown, we speculate that the radiographic infiltrates in this case resulted from microthrombi
similar to those seen at autopsy in Case One. Both the thrombus and infiltrates resolved with
thrombolytic therapy.
89% of neonatal cases symptomatic venous thromboembolism (VTE) in the neonate are
secondary to a CVL.[2] Other reported risk factors include surgery and sepsis as seen in Case
One, as well as other risks not seen in our cases including maternal diabetes, prolonged
immobilization (with or without the use of paralytic drugs), polycythemia, asphyxia,
hypotension, dehydration, closure of the ductus arteniosus, and hypercoagulable disorders.[1, 2, 912, 23]

The standard for diagnosis of VTE is angiography. Doppler ultrasound is less invasive and can
be performed at the bedside. In one reported series, however, the accuracy of ultrasound was
poor when compared to contrast venography in detecting asymptomatic thrombi.[13] We presume
Case One had a thrombus of the iliofemoral veins or IVC with the observed clinical symptoms of
leg discoloration and swelling, as well as prominence of the superficial abdominal wall veins
despite two negative ultrasound studies. Because the thrombus found at autopsy in the
pulmonary artery was well organized, we speculate that it likely formed over a prolonged period
of time before terminally moving to obstruct the main pulmonary artery.
PE has been diagnosed in neonates by echocardiography,[5-7, 9] cardiac catheterization, [14] V/Q
scan,[6, 12] and CT angiography.[6] Cardiac catheterization with angiography is the gold standard
for diagnosis of PE and also provides a means for treatment via thrombectomy.[15]
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Optimal therapy for vascular thrombosis in the neonate has not been defined.[16] Reported
options include anticoagulation with heparin or LMWH, thrombolytic therapy with t-PA,
surgery, and catheter-based embolectomy.[6, 7, 9, 12, 14, 15, 17-19] We chose t-PA and LMWH because
it is the most studied option. t-PA has a short half-life, nonantigenic qualities, and local specific
action on plasminogen bound fibrin.[20] Catheter directed therapy has been shown to be superior
to systemic t-PA therapy in the rabbit model of SVC thrombosis.[21]
In a literature review of 94 cases of neonatal thrombus treated with t-PA, infusion rate ranged
from 0.02-1mg/kg/hour, a duration of administration from ½-264 hours, and an initial bolus of 00.75mg/kg.[22] Thrombolysis with concomitant heparin may be synergistic; however, whether
LMWH or unfractionated heparin (UFH) is better is still unclear. The potential advantages of
LMWH when compared with UFH include a more predictable pharmacokinetic profile, minimal
monitoring, subcutaneous administration and potentially less bleeding and osteopenia.[6, 18]
In summary, we recommend PE be considered in any previously stable neonate with sudden
onset of respiratory failure and history of CVL. We, like others, feel there is a need for a
multicenter trial to evaluate the most effective therapeutic intervention for vascular thrombosis in
the newborn.

9

References
[1]

U. Nowak-Göttl, R. vonKries, U. Göbel. Neonatal symptomatic thromboembolism in
Germany: two year survey, Arch Dis Fetal Neonatal Ed, 76 (1997), F163-F167.

[2]

B. Schmidt, M. Andrew. Neonatal thrombosis: report of a prospective Canadian and
international registry, Pediatrics, 96 (1995), 939-43.

[3]

M. Andrew, M. David, M. Adams, et al. Venous thromboembolic complications (VTE)
in children: first analysis of the Canadian registry of VTE, Blood, 83 (1994), 1251-57.

[4]

J. R. Buck, R. H. Connors, W. W. Coon, W. H. Weintraub, J. R. Wesley, A. G. Coran.
Pulmonary embolism in children, J Pedatr Surg, 16 (1981), 385-91.

[5]

K. J. Pugh, S. B. Jureidini, R. Ream, P. Syamasuendur Rao, J. Dossier. Successful
Thrombolytic therapy of pulmonary embolism associated with urosepsis in an infant,
Pediatr Cardo, 23 (2002), 77-79.

[6]

T. Sawyer, A. Antle, M. Studer, M. Thompson, S. Perry, C. Mahnke. Neonatal
pulmonary artery thrombosis presenting as persistent pulmonary hypertension of the
newborn, Pediatr Cardiol, [Epub ahead of print] 2008.
http://www.ncbi.nlm.nih.gov/pubmed/19052800?dopt=abstractplus

[7]

M. M. Goble, C. A. Gomez. Neonatal pulmonary artery thrombosis: echocardiographic
characteristics and possible contributing factors, J Am Soc Echocardiog, 18 (2005), e1e4.

[8]

L. A. Pyles, M.E. Pierpont, M.E. Steiner, P. S. Hesslein, C.M.Smith. Fibrinolysis by
tissue plasminogen activator in a child with pulmonary embolism, J Pediatr, 116 (1990),
801-04.

10

[9]

S. Clapp, M. Bedard, Z. Q. Farooki, E. Arciniegas. Pulmonary artery thrombus
associated with the ductus arteriosus, Am Heart J, 111 (1986), 796-7.

[10]

E. H. Oppenheimer, J. R. Esterly. Thrombosis in the newborn: comparison between
infants of diabetic and nondiabetic mothers, J Pediatr, 67 (1965), 549-56.

[11]

D. S. Beardsley. Venous thromboembolism in the neonatal period, Semperi, 31 (2007),
250-53.

[12]

J. Arnold, H. O’Brodovich, R. Whyte, G. Coates. Pulmonary thromboemboli after
neonatal asphyxia. J Pediatr, 106 (1985), 806-9.

[13]

M. Roy, S. Turner-Gomes, G. Gill, C. Way, J. Mernagh, B, Schmidt. Accuracy of
Doppler echocardiography for the diagnosis of thrombosis associated with umbilical
venous catheters, J. Pediatr, 140 (2002), 131-34.

[14]

A. Greenway, M. Massicotte, P. Monagle. Neonatal thrombosis and its treatment, Blood
Rev, 18 (2004), 75-84.

[15]

J. Feldman, J. Feinstein, J. Lamberiti, S. Perry. AngioJet catheter – based thrombectomy
in a neonate with postoperative pulmonary embolism, Catheter Cardiovasc Inteven, 66
(2005), 442-45.

[16]

C. M. John, C. Harkensee. Thrombolytic agents for arterial and venous thromboses in
neonates (review), Cochrane Database Syst Rev, Issue 1( 2005) CDOO4342.
DOI:10.1002/14651858.CD004342.pub2.

[17]

E. Chalmers. Neonatal thrombosis, J. Clin Pathol, 53 (2000), 419-23.

[18]

D. Kenny, B. Tsai-Goodman. Neonatal arterial thrombus mimicking congenital heart
disease, Arch Dis Child Fetal Neontal Ed, 92 (2007), F59-F61.

11

[19]

A. Gamillscheg, J. Nürnberg, V. Alexi-Meskishvili, et al. Surgical emergency
embolectomy for the treatment of fulminant pulmonary embolism in a preterm infant, J.
Pediatr Surg, 32 (1997), 1516-18.

[20]

R. W. Holden. Plasminogen activators: pharmacology and therapy, Radiology, 174
(1990), 993-1001.

[21]

D. Collen, J. M. Stassen, M. Verstraete. Thrmobolysis with human extrinsic (tissue-type)
plasminogen activator in rabbits with experimental jugular vein thrombosis, J Clin Invest,
71 (1983), 368-76.

[22]

J. Hartman, A. Hussein, B. Trowitzsch. Treatment of neonatal thrombus formation with
recombinant tissue plasminogen activator: six years experience and review of the
literature, Arch Dis Child Fetal Neonatal Ed, 85 (2001), F18-22.

[23]

M. J. Manco-Johnson. Disorders of hemostasis in childhood: risk factors for venous
thromboembolism, Thromb Haemost, 78 (1997), 710-14.

